Adam Schussheim, MSc, MD
DownloadHi-Res Photo
About
Appointments
Radiology & Biomedical Imaging
Clinical InstructorPrimary
Other Departments & Organizations
- Advanced Cardiovascular CT/MR Program
- Radiology & Biomedical Imaging
- Yale Medicine
Education & Training
- Fellowship
- National Heart, Lung, and Blood Institute / NIH (2000)
- Fellowship
- Mount Sinai Medical Center (1999)
- Internship & Residency
- New York Presbyterian Health System / Cornell Medical Center (1996)
- MD
- Harvard Medical School (1993)
- MSc
- University of Oxford, Biochemistry (1991)
- BA
- Yale University, Physics (1988)
Board Certifications
Cardiovascular Computed Tomography
- Certification Organization
- Certification Board of Cardiovascular Computed Tomography
- Latest Certification Date
- 2019
- Original Certification Date
- 2008
Nuclear Cardiology
- Certification Organization
- Certification Board of Nuclear Cardiology
- Original Certification Date
- 2001
Cardiovascular Disease
- Certification Organization
- AB of Internal Medicine
- Latest Certification Date
- 2019
- Original Certification Date
- 1999
Internal Medicine
- Certification Organization
- AB of Internal Medicine
- Latest Certification Date
- 2020
- Original Certification Date
- 1996
Research
Research at a Glance
Yale Co-Authors
Frequent collaborators of Adam Schussheim's published research.
Publications Timeline
A big-picture view of Adam Schussheim's research output by year.
Edward J Miller, MD, PhD
Erica Spatz, MD, MHS
Erin Faherty, MD
Ian Ferguson, MD
Jamieson O'Marr, MS
Jennifer M. Kwan, MD/PhD
26Publications
692Citations
Publications
Featured Publications
Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension
Phillips RA, Xu J, Peterson LE, Arnold RM, Diamond JA, Schussheim AE. Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension. Journal Of The American College Of Cardiology 2018, 71: 1601-1610. PMID: 29525494, DOI: 10.1016/j.jacc.2018.01.074.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsSignificant serious adverse eventsPrimary outcome eventIntensive treatment groupCVD riskOutcome eventsHarm ratioIntensive treatmentTreatment groupsTreatment guidelinesAmerican CollegeCardiology/American Heart AssociationFuture cardiovascular disease riskCox proportional hazards modelBaseline CVD riskQuartiles of baselineSerious adverse eventsBlood pressure treatmentCardiovascular disease riskAmerican Heart AssociationProportional hazards modelLower ratesSPRINT populationAdverse eventsCardiovascular riskPrimary outcomePatient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease).
Hachamovitch R, Nutter B, Hlatky MA, Shaw LJ, Ridner ML, Dorbala S, Beanlands RS, Chow BJ, Branscomb E, Chareonthaitawee P, Weigold WG, Voros S, Abbara S, Yasuda T, Jacobs JE, Lesser J, Berman DS, Thomson LE, Raman S, Heller GV, Schussheim A, Brunken R, Williams KA, Farkas S, Delbeke D, Schoepf UJ, Reichek N, Rabinowitz S, Sigman SR, Patterson R, Corn CR, White R, Kazerooni E, Corbett J, Bokhari S, Machac J, Guarneri E, Borges-Neto S, Millstine JW, Caldwell J, Arrighi J, Hoffmann U, Budoff M, Lima J, Johnson JR, Johnson B, Gaber M, Williams JA, Foster C, Hainer J, Di Carli MF. Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). Journal Of The American College Of Cardiology 2012, 59: 462-74. PMID: 22281249, DOI: 10.1016/j.jacc.2011.09.066.Peer-Reviewed Original Research
2024
CARDIAC MASS IN RIGHT ATRIUM: IMPORTANCE OF EVALUATION WITH CARDIAC MAGNETIC RESONANCE IMAGING
Jeyashanmugaraja G, Marrinan G, Schussheim A. CARDIAC MASS IN RIGHT ATRIUM: IMPORTANCE OF EVALUATION WITH CARDIAC MAGNETIC RESONANCE IMAGING. Journal Of The American College Of Cardiology 2024, 83: 1545. DOI: 10.1016/s0735-1097(24)03535-6.Peer-Reviewed Original ResearchKiosk 3Q-TA-04 Cardiac Mass in Right Atrium: Importance of Evaluation with Cardiac Magnetic Resonance Imaging
Jeyashanmugaraja G, Marrinan G, Huber S, Schussheim A. Kiosk 3Q-TA-04 Cardiac Mass in Right Atrium: Importance of Evaluation with Cardiac Magnetic Resonance Imaging. Journal Of Cardiovascular Magnetic Resonance 2024, 26: 100494. DOI: 10.1016/j.jocmr.2024.100494.Peer-Reviewed Original Research
2022
Short-Term Outcomes After Myopericarditis Related to COVID-19 Vaccination
Pareek M, Steele J, Asnes J, Baldassarre L, Casale L, Desai N, Elder R, Faherty E, Ferguson I, Fishman R, Ghazizadeh Z, Glick L, Hall E, Khera R, Kokkinidis D, Kwan J, O'Marr J, Schussheim A, Tuohy E, Wang Y, Spatz E, Jacoby D, Miller E. Short-Term Outcomes After Myopericarditis Related to COVID-19 Vaccination. JACC Cardiovascular Imaging 2022, 15: 2002-2005. PMID: 36357140, PMCID: PMC9094612, DOI: 10.1016/j.jcmg.2022.03.026.Peer-Reviewed Case Reports and Technical NotesCitationsAltmetric
2021
Another Nudge to Overcome the Treatment-Risk Paradox in Blood Pressure Management ∗
Diamond J, Schussheim A, Phillips R. Another Nudge to Overcome the Treatment-Risk Paradox in Blood Pressure Management ∗. Journal Of The American College Of Cardiology 2021, 77: 1991-1993. DOI: 10.1016/j.jacc.2021.03.230.Peer-Reviewed Original ResearchAltmetric
2019
FLOATING LEFT ATRIAL MASS IN A PATIENT WITH PROSTHETIC MITRAL VALVE: MANAGEMENT DILEMMA
Jeyashanmugaraja G, Mahmut A, Clarke J, Roy T, Schussheim A. FLOATING LEFT ATRIAL MASS IN A PATIENT WITH PROSTHETIC MITRAL VALVE: MANAGEMENT DILEMMA. Journal Of The American College Of Cardiology 2019, 73: 2356. DOI: 10.1016/s0735-1097(19)32962-6.Peer-Reviewed Original Research
2017
Dabigatran-Induced Spontaneous Hemopericardium and Cardiac Tamponade.
Jelani QU, Gordon R, Schussheim A. Dabigatran-Induced Spontaneous Hemopericardium and Cardiac Tamponade. Texas Heart Institute Journal / From The Texas Heart Institute Of St. Luke's Episcopal Hospital, Texas Children's Hospital 2017, 44: 370-372. PMID: 29259514, PMCID: PMC5731597, DOI: 10.14503/THIJ-16-6073.Peer-Reviewed Original Research
2011
Dipyridamole-Associated Shock and Pulmonary Edema
Dioverti M, Fishman R, Moskowitz R, Arias SA, Nair S, Lall P, Schussheim AE, Zarich S, Manthous C. Dipyridamole-Associated Shock and Pulmonary Edema. Annals Of Pharmacotherapy 2011, 45: 1027-1027. PMID: 21672887, DOI: 10.1345/aph.1p734.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsNoncardiogenic pulmonary edemaDipyridamole myocardial scintigraphyPulmonary edemaSevere pulmonary edemaCardiopulmonary collapseMyocardial scintigraphyNew left ventricular dysfunctionPositive end-expiratory pressureObjective causality assessmentLeft ventricular dysfunctionEnd-expiratory pressureMechanism of shockFulminant shockInvasive ventilationMultiple vasopressorsCardiovascular collapseHypovolemic shockShock refractoryCase seriesDipyridamole infusionEchocardiography resultsEndotracheal intubationIntravenous dipyridamoleContinuous infusionIntravenous infusionDipyridamole-Associated Refractory Shock And Pulmonary Edema
Prono M, Fishman R, Moskowitz R, arias S, Nair S, Lall P, Schussheim A, Zarich S, Manthous C. Dipyridamole-Associated Refractory Shock And Pulmonary Edema. 2011, a3879-a3879. DOI: 10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a3879.Peer-Reviewed Original Research
News
News
Get In Touch
Contacts
Appointment Number